Tacrolimus granules + Tacrolimus granules

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

Liver Transplantation

Conditions

Liver Transplantation, Kidney Transplantation

Trial Timeline

Dec 30, 2021 → Mar 14, 2024

About Tacrolimus granules + Tacrolimus granules

Tacrolimus granules + Tacrolimus granules is a approved stage product being developed by Astellas Pharma for Liver Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT05153915. Target conditions include Liver Transplantation, Kidney Transplantation.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT05152628ApprovedCompleted
NCT05153915ApprovedCompleted

Competing Products

20 competing products in Liver Transplantation

See all competitors
ProductCompanyStageHype Score
LanifibranorInventivaPhase 2
47
GODEX + PlaceboCelltrionPhase 3
77
peginterferon alfa-2a 180μg + peginterferon alfa-2a 90μg + ribavirinChugai PharmaceuticalPhase 3
77
exatecan mesylateDaiichi SankyoPhase 2
52
TacrolimusAstellas PharmaPre-clinical
23
ATG (Fresenius Biotech)Astellas PharmaPhase 2
52
Advagraf + Prograf + PrografAstellas PharmaApproved
85
Prograf + AdvagrafAstellas PharmaApproved
85
ADVAGRAF®Astellas PharmaApproved
85
Prograf + MR4Astellas PharmaPhase 3
77
tacrolimus modified release (MR) + tacrolimusAstellas PharmaPhase 2
52
tacrolimus modified release (MR) + tacrolimusAstellas PharmaPhase 2
52
tacrolimusAstellas PharmaPhase 3
77
Prograf-XL + Prograf + MMFAstellas PharmaPhase 3
77
micafungin + fluconazole + liposomal amphotericin B + caspofunginAstellas PharmaPhase 3
77
FK506E (modified release tacrolimus) + Prograf (tacrolimus)Astellas PharmaPhase 3
77
FK778Astellas PharmaPhase 2
52
Tacrolimus modified-release + PrografAstellas PharmaPhase 3
77
Advagraf + PrografAstellas PharmaApproved
85
Prograf + FK506MR capsuleAstellas PharmaPhase 3
77